XML 107 R69.htm IDEA: XBRL DOCUMENT v3.20.1
Earnings per Share (Details) - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Numerator:    
Net income attributable to Biogen Inc. $ 1,399.1 $ 1,408.8
Weighted-average shares used in calculating:    
Weighted average number of common shares outstanding 172.8 196.6
Effect of dilutive securities:    
Dilutive potential common shares 0.3 0.4
Shares used in calculating diluted earnings per share 173.1 197.0
Time-vested restricted stock units    
Effect of dilutive securities:    
Stock units 0.1 0.3
Market stock units    
Effect of dilutive securities:    
Stock units 0.1 0.1
Performance stock units settled in stock    
Effect of dilutive securities:    
Stock units 0.1 0.0